Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

    Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

    Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

    We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

    1. Home

    2. Perspectives

    3. Co-existing Coronary Artery Disease in a Patient with Hypertrophic Cardiomyopathy Detected by 82Rb PET/CT Myocardial Perfusion Study
    Imaging

    Co-existing Coronary Artery Disease in a Patient with Hypertrophic Cardiomyopathy Detected by 82Rb PET/CT Myocardial Perfusion Study

    1min
    Parthiban Arumugam, MD
    Published on April 14, 2018
    <p>A 58-year-old man with a history of hypertrophic cardiomyopathy (HCM) presented with tightness in the chest and occasional chest pain. The patient had previously been treated with alcohol septal ablation for a left ventricular outflow tract (LVOT) obstruction secondary to HCM. The patient also had several risk factors for coronary artery disease including high BMI (36), hypertension, and diabetes. In view of the clinical possibility of coronary artery disease coexisting with hypertrophic cardiomyopathy, the patient was referred to a stress-rest <sup>82</sup>Rb PET/CT myocardial perfusion (MPI) study.</p>
    By Parthiban Arumugam, MD
    Data courtesy of Manchester Royal Infirmary, Manchester, England
    1. The outcomes by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.